Signaling Pathways - MAGL - CCR - ErbB - IDH2
清除全部
- B1543 Mubritinib (TAK 165)中文名: 木利替尼Target: ErbBSummary: HER2/ErbB2有效抑制剂
- A8375 AZD8931 (Sapitinib)中文名: 沙普替尼Target: EGFR|ErbBSummary: ErbB抑制剂
- A8319 Dacomitinib (PF299804, PF299)中文名: 达克替尼Target: ErbBSummary: HER抑制剂
- A8311 Maraviroc2 Citation中文名: 马拉维若Target: CCRSummary: CCR5选择性拮抗剂,抗逆转录病毒药物
- A8218 Lapatinib2 Citation中文名: 拉帕替尼Target: ErbBSummary: EGFR/HER2抑制剂
- A3494 INCB3344Target: CCRSummary: CCR2趋化因子受体拮抗剂
- A3146 AGI-6780Target: IDH2Summary: IDH2/R140Q突变抑制剂
- A4092 CUDC-1011 CitationTarget: Histone Deacetylases (HDACs)|EGFR|ErbBSummary: 多靶点HDAC抑制剂
- N1846 Tanshinone IIA中文名: 丹参酮IIATarget: AP-1|MAGLSummary: 抗氧化和抗炎剂